Information
-
Trademark
-
87390143
-
Serial Number
87390143
-
Registration Number
5788300
-
International Classifications
-
Filing Date
March 29, 2017
7 years ago
-
Registration Date
June 25, 2019
5 years ago
-
Transaction Date
June 25, 2024
7 months ago
-
Status Date
June 25, 2019
5 years ago
-
Published for Opposition Date
February 20, 2018
6 years ago
-
Location Date
June 03, 2022
2 years ago
-
First Use Anywhere Date
January 01, 2016
9 years ago
-
First Use In Commerce Date
January 01, 2016
9 years ago
-
Status Code
700
-
Current Location
TMO LAW OFFICE 124
Employee Name
BHUPATHI, TARA LUISE
-
Attorney Docket Number
3814.0250000
Attorney Name
Monica Riva Talley
Law Office Assigned Location Code
N60
-
Owners
Case File Statements
- DM0000: The mark consists of starburst patterned logo with eight points.
- A00001: Issue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
- GS0051: Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations
- CC0000: Color is not claimed as a feature of the mark.
- GS0441: Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals
- GS0421: Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials
Case File Event Statements
-
6/28/2017 - 7 years ago
5 - PRIORITY ACTION WRITTEN
Type: CPRA
-
4/1/2017 - 7 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/4/2017 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/5/2017 - 7 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
6/21/2017 - 7 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/10/2018 - 7 years ago
15 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
6/28/2017 - 7 years ago
6 - PRIORITY ACTION E-MAILED
Type: GPRA
-
6/28/2017 - 7 years ago
7 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
12/22/2017 - 7 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
12/22/2017 - 7 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
12/23/2017 - 7 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
12/22/2017 - 7 years ago
11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
1/10/2018 - 7 years ago
12 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
1/10/2018 - 7 years ago
13 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
1/10/2018 - 7 years ago
14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
1/10/2018 - 7 years ago
16 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/18/2018 - 6 years ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/31/2018 - 6 years ago
17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
2/20/2018 - 6 years ago
18 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
2/20/2018 - 6 years ago
19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
4/17/2018 - 6 years ago
20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
10/16/2018 - 6 years ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/16/2018 - 6 years ago
22 - SOU EXTENSION 1 FILED
Type: EXT1
-
10/16/2018 - 6 years ago
23 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
10/16/2018 - 6 years ago
25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
4/11/2019 - 5 years ago
26 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
5/18/2019 - 5 years ago
30 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
5/21/2019 - 5 years ago
31 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA
-
6/25/2019 - 5 years ago
32 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
1/6/2022 - 3 years ago
33 - TEAS SECTION 7 REQUEST RECEIVED
Type: ES7R
-
4/11/2019 - 5 years ago
28 - USE AMENDMENT FILED
Type: IUAF
-
4/24/2019 - 5 years ago
27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
4/24/2019 - 5 years ago
29 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
6/2/2022 - 2 years ago
34 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
6/3/2022 - 2 years ago
35 - NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Type: C.7C
-
6/25/2024 - 7 months ago
36 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1